Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Wenzler

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Msystems|September 14, 2021
Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniaeZackery P Bulman, Fiorella Krapp, Nathan B Pincus, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult ParticipantsEric Wenzler, Susan C Bleasdale, Monica Sikka, et al.
The Journal of Antimicrobial Chemotherapy|October 20, 2021
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniaeYanqin Huang, Amisha P Rana, Eric Wenzler, et al.
Open Forum Infectious Diseases|January 30, 2020
In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> and Carbapenem-Resistant <i>Enterobacter cloacae</i> Bacteremia in a Liver Transplant PatientEric Wenzler, Maressa Santarossa, Kevin A Meyer, et al.
British Journal of Clinical Pharmacology|April 15, 2020
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplantKaren Sweiss, Bhaskar Vemu, Craig C Hofmeister, et al.
Anaerobe|June 25, 2017
Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infectionKarri A Bauer, Jessica E W Johnston, Eric Wenzler, et al.
Heart & Lung : the Journal of Critical Care|June 8, 2023
Comparison of thrombotic and clinical outcomes in SARS-CoV-2-pneumonia versus other viral pneumonia in an urban academic medical centerRachel Goldberg, William Ye, Kevin Johns, et al.
Clinical Transplantation|June 18, 2019
A randomized, open-label pharmacokinetic trial of tacrolimus extended-release dosing in obese de novo kidney transplant recipientsNatalia M Jasiak-Panek, Eric Wenzler, Shree Patel, et al.
Journal of Clinical Microbiology|April 18, 2023
Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution TestHarley Harris, Lili Tao, Emily B Jacobs, et al.
Infection Control and Hospital Epidemiology|September 5, 2020
Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance dataDavid A Butler, Mark Biagi, Vikas Gupta, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Msystems|September 14, 2021
Genomic Features Associated with the Degree of Phenotypic Resistance to Carbapenems in Carbapenem-Resistant Klebsiella pneumoniaeZackery P Bulman, Fiorella Krapp, Nathan B Pincus, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult ParticipantsEric Wenzler, Susan C Bleasdale, Monica Sikka, et al.
The Journal of Antimicrobial Chemotherapy|October 20, 2021
Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniaeYanqin Huang, Amisha P Rana, Eric Wenzler, et al.
Open Forum Infectious Diseases|January 30, 2020
In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant <i>Enterococcus faecium</i> and Carbapenem-Resistant <i>Enterobacter cloacae</i> Bacteremia in a Liver Transplant PatientEric Wenzler, Maressa Santarossa, Kevin A Meyer, et al.
British Journal of Clinical Pharmacology|April 15, 2020
Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplantKaren Sweiss, Bhaskar Vemu, Craig C Hofmeister, et al.
Anaerobe|June 25, 2017
Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infectionKarri A Bauer, Jessica E W Johnston, Eric Wenzler, et al.
Heart & Lung : the Journal of Critical Care|June 8, 2023
Comparison of thrombotic and clinical outcomes in SARS-CoV-2-pneumonia versus other viral pneumonia in an urban academic medical centerRachel Goldberg, William Ye, Kevin Johns, et al.
Clinical Transplantation|June 18, 2019
A randomized, open-label pharmacokinetic trial of tacrolimus extended-release dosing in obese de novo kidney transplant recipientsNatalia M Jasiak-Panek, Eric Wenzler, Shree Patel, et al.
Journal of Clinical Microbiology|April 18, 2023
Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution TestHarley Harris, Lili Tao, Emily B Jacobs, et al.
Infection Control and Hospital Epidemiology|September 5, 2020
Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance dataDavid A Butler, Mark Biagi, Vikas Gupta, et al.
Pageof 8